olezarsen
Ionisā olezarsen slashes triglycerides and pancreatitis in rare disease patients
Anika Sharma
Ionis Pharmaceuticals has achieved a significant milestone in its phase 3 clinical trial for lipid-lowering therapy, bringing the company closer ...
